Medtronic plc (NYSE: MDT ), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the EvolutTM ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut� ...

This was the fifth straight quarter of double-digit growth, Kumar said. Medtronic sells insulin pumps and continuous glucose monitors, or CGMs. "Interesting, MDT noted that it was investing ...

Medtronic is one of the largest medical device makers in the world. The stock's dividend yield stands at a historically high 3.1%. Medtronic has increased its dividend annually for 47 consecutive ...

Medtronic explores options to optimize manufacturing ... December 5, 2024 Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case Medical device maker Insulet convinced ...

GALWAY, Ireland, Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of ...

Medtronic plc, headquartered in Galway ... surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and ...

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...